PSYCHIATRY

Academic Publications

The following is representative listing of academic publications of the Department of Psychiatry.

1. Abraham PF, Calabrese JR: Evidenced-Based Pharmacologic Treatment of Borderline Personality Disorder: A Shift from SSRIs to Anticonvulsants and Atypical Antipsychotics?" Research Report in Journal Affective Disorders. 2008 Feb 25 [Epub ahead of print].
2. Abulseoud OA, Hellman G, Calabrese JR, Verduin ML, Chirichigno JW, McKowen J, Gitlin MJ, Altshuler LL, Frye MA: Gender and bipolar subtype’s association with self-reported hazardous alcohol consumption in bipolar depression. Journal of Dual Diagnosis. In Press.
3. Altamura AC, Mundo E, Dell’Osso B, Tacchini G, Buoli M, Calabrese JR: Quetiapine and classical mood stabilizers in the long-term treatment of bipolar disorder: A 4-year follow-up naturalistic study. J Affect Disord. 2008 Mar 8; [Epub ahead of print].
4. Alex KD, Pehek EA.  Pharmacologic mechanisms of serotonergic regulation of dopamine
   neurotransmission. Pharmacol Ther. 2007 Feb;113(2):296-320.
5. 5.   Arnold LE, Lindsay RL, Lopez FA, Jacob SE, Biederman J, Findling RL, Ramadan Y. Treating attention deficit hyperactivity disorder with a stimulant transdermal patch: the clinical art. Pediatrics, 120, 1100-1106, 2007
6. Arnsten AF, Scahill L, Findling RL. Alpha-2 adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. Journal of Child and Adolescent Psychopharmacology, 17, 393-406, 2007
7. Azorin JM, Findling RL. Valproate use in children and adolescents with bipolar disorder. CNS Drugs, 21, 1019-1033, 2007
8. Barzman DH, Findling RL. Pharmacological treatment of pathologic aggression in children. International Review of Psychiatry, 20, 151-157, 2008
9. Berk M, NG F, Wang WV, Calabrese JR, Mitchell PB, Malhi GS, Tohen M: The empirical redefinition of the psychometric criteria for remission in bipolar disorder. Journal of Affective Disorders. 2008 Feb;106(1-2):153-8. Epub 2007 Jul 26.
10. Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clinical Therapeutics, 29, 450-463, 2007
11. Bongiovanni R, Newbould E, Jaskiw GE. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.  Brain Res. 2008 Jan 23;1190:39-48.
12. Calabrese JR, Guelfi JD, Perdrizet-Chevallier C, and the Agomelatine Bipolar Study Group: Agomelatine adjunctive therapy for acute bipolar depression: Preliminary open data. Bipolar Disorders. 2007 Sept;9(6):628-35.
13. Calabrese JR, Kemp DE: Bipolar drug development: Are we getting closer to the real world? Am J Psychiatry. In Press.
14. Calabrese JR, Huffman RF, White RL, Edwards S, Thompson TR, Ascher JA, Monaghan E, Leadbetter RA: Lamotrigine in the acute treatment of bipolar depression: Results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008 Mar;10(2):323-333.
15. Chen P, Kales HC, Weintraub D, Blow FC, Jiang L, Ignacio RV, Mellow AM. Depression in Veterans with Parkinson’s Disease: Frequency, Co-Morbidity, and Healthcare Utilization. Int. J Geriatric Psychiatry; 22:543-548, 2007
16. 16.  Chen P, Kales HC, Weintraub D, Blow FC, Jiang L, Mellow AM. Antidepressant Treatment of Veterans with Parkinson’s Disease and Depression: Analysis of a National Sample. Journal of Geriatric Psychiatry and Neurology 2007; 20(3):161-165
17. Cerny CA, Noffsinger SG. Legal Digest: Prisoner Rights and Suicide. The Journal of the American Academy of Psychiatry and the Law. 2007; 34: 549-551.
18. Corradi, RB., Turning passive into active: a building block of ego and fundamental mechanism of defense. Journal of The American Academy of Psychoanalysis and Dynamic Psychiatry, 35(3), 393-416, 2007.
19. Corradi, RB., The repetition compulsion in psychodynamic psychotherapy. Journal of The American Academy of Psychoanalysis and Dynamic Psychiatry, In Press.
20. Dalton WT, Nelson DV, Brobst JB, Lindsay JE, Friedman LC.  Psychosocial variables associated with husbands’ adjustment three months following wives’ diagnosis of breast cancer.  Journal of Cancer Education 2007:22;245-249
21. Delos Reyes CM, Ronis RJ: Advancing evidence-based practices through psychiatric consultation. Letter to the editor. Psychiatric Services 2006; 57(7), 1047.
22. Drotar D, Neff Greenley R, Demeter CA, McNamara NK, Stansbrey RJ, Calabrese JR, Stange J, Vijay P, Findling RL. Adherence to pharmacological treatment for juvenile bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 831-839, 2007.
23. Duax JM, Youngstrom EA, Calabrese JR, Findling RL. Sex differences in pediatric bipolar disorder. Journal of Clinical Psychiatry, 68, 1565-1573, 2007
24. Du Rocher Schudlich TD, Youngstrom EA, Calabrese JR, Findling RL: The role of the family functioning in bipolar disorder in families. J Abnorm Child Psych 2008 Feb 13 [Epub ahead of print].
25. Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y. Efficacy and safety of venlafaxine ER in the treatment of pediatric major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 479-488, 2007
26. Findling RL. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. Journal of Clinical Psychiatry, 69 (suppl 4), 9-14, 2008
27. Findling RL. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Clinical Therapeutics, 30, 942-957, 2008
28. Findling RL, Arnold LE, Greenhill LL, Kratochvil CJ, McGough JJ. Diagnosing and managing complicated ADHD. Journal of Clinical Psychiatry, 68, 1963-1970, 2007  Republished in The Primary Care Companion to the Journal of Clinical Psychiatry, 10, 229-236, 2008
29. Findling RL, Bukstein OG, Melmed RD, Lopez FA, Sallee FR, Arnold LE, Pratt RD. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 69, 149-159, 2008
30. Findling RL, Frazier TW, Youngstrom EA, McNamara NK, Stansbrey RJ, Gracious BL, Reed MD, Demeter CA, Calabrese JR. Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder. Journal of Clinical Psychiatry, 68, 781-788, 2007
31. Findling RL, Greenhill LL, McNamara NK, Demeter CA, Kotler LA, O’Riordan MA, Myers C, Reed MD. Venlafaxine in the treatment of children and adolescents with attention deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17, 433-445, 2007
32. Findling RL, Kauffman RE, Sallee FR, Carson WH, Nyilas M, Mallikaarjun S, Shoaf SE, Forbes RA, Boulton D, Pikalov A. The tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study. Journal of Clinical Psychopharmacology, 28, 441-446, 2008
33. Findling RL, Newcorn JH, Malone RP, Waheed A, Prince JB, Kratochvil CJ. Pharmacotherapy of aggression in a 9-year-old with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 653-658, 2007
34. Findling RL, Short EJ, McNamara NK, Demeter CA, Stansbrey RJ, Gracious BL, Whipkey R, Manos MJ, Calabrese JR. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1445-1453, 2007
35. Flanders, SC, Findling RL, Youngstrom EA, Pandina G, Rupnow MFT, Jensik SE, Carlson GA. Clinical and economic outcomes in pediatric inpatients treated with atypical antipsychotics. Journal of Child and Adolescent Psychopharmacology, 17, 312-327, 2007
36. Frazier TW, Demeter CA, Youngstrom EA, Calabrese JR, Stansbrey RJ, McNamara NK, Findling RL. Evaluation and comparison of psychometric instruments for pediatric bipolar spectrum disorders in four age groups. Journal of Child and Adolescent Psychopharmacology, 17, 853-866, 2007
37. Frazier JA, McClellan J, Findling RL, Vitiello B, Anderson R, Zablotsky B, Williams E, Maloney AE, Ritz L, Hamer RM, Noyes N, Lieberman JA, Sikich LM. Treatment of early-onset schizophrenia and schizoaffective disorder: demographic and clinical characteristics. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 979-988, 2007
38. Freedman R, Ross R, Michels R, Appelbaum P, Siever L, Binder R, Carpenter W, Hatters Friedman S, Resnick P, Rosenbaum J. Psychiatrists, Mental Illness and Violence. American Journal of Psychiatry, 2007; 164: 1315-1317.
39. Friedman, L.C., Elledge, R., Chang, J., Kalidas, M., Dulay, M.F., Lynch, G.R., & Osborne, C.K.  Attribution of blame and self-forgiving attitude as predictors of mood disturbance and quality of life in women with breast cancer.  Journal of Behavioral Medicine, May 12; [Epub ahead of print], 2007.
40. Friend, K.B., & Pagano, M.E. (2007). Timevarying predictors of smoking cessation among individuals in treatment for alcohol abuse and dependence: findings from Project Match. Alcohol and Acoholism, 42(3), 234-240.
41. Gajwani P, Calabrese JR. Update on quetiapine in treatment of bipolar disorder: results from Bolder Trials. Neuropsychiatric disease and treatment. In Press.
42. Gallitano-Mendel A, Wozniak DF, Pehek EA, Milbrandt J. Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects. Neuropsychopharmacology. 2008 May;33(6):1266-75.
43. Gao K, Kemp DE, Ganocy SJ, Muzina DJ, Xia G, Findling RL, Calabrese JR: Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disorders. In Press.
44. Gao K, Verduin ML, Kemp DE, Tolliver B, Ganocy SJ, Elhaj O, Bilali S, Brady K, Findling RL, Calabrese JR: Clinical correlates of patients with rapid cycling bipolar disorder and a recent history of substance use disorder: A subtype comparison from two randomized, placebo-controlled trials. J Clin Psychiatry. June 24,2008: e1-e7.
45. Gao K, Kemp DE, Gajwani P, Xia G, Ganocy SJ, Calabrese JR: Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: A Systematic Review. J Clin Psychopharmacology. 2008;28(2):203-9.
46. Gao K, Ganocy SJ, Gajwani P, Muzina DJ, Kemp DE, Calabrese JR: A review of the sensitivity and tolerability of patients with bipolar disorder or schizophrenia to antipsychotics: focus on somnolence. J Clin Psychiatry. 2008 Feb;69(2):302-9.
47. Gao K, Tolliver B, Kemp DE, Verduin ML, Ganocy SJ, Bilali S, Brady K, Shim SS, Findling RL, Calabrese JR: Differential interactions between comorbid anxiety disorders and substance use disorders in rapid cycling bipolar I or II disorder. J Affect Disorders. 2008 Jan 28; [Epub ahead of print].
48. Geddes JR, Calabrese JR, Goodwin GM: Lamotrigine for treatment of bipolar depression: An independence meta-analysis and meta-regression of individual patient data from 5 randomized trials. Br J Psychiatry. In Press.
49. Ghaemi SN, Bauer M, Cassidy F, Malhi GS, Mitchell P, Phelps J, Vieta E, Youngstrom E, for the ISBD Diagnostic Guidelines Task Force. Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. Bipolar Disorders, 10: 117-128, 2008
50. Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Araga M, Wisniewski S, Miklowitz DJ, Thase ME, Sachs GS, Thase M: Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: Findings from the STEP-BD. Am J Psychiatry. 2007 Sept;164(9)1348-55.
51. Goldberg JF, Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, Suppes T, Post RM: Six-month prospective life charting of mood symptoms with Lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry. 2008 Jan 1;63(1):125-30. Epub 2007 Jun 1
52. Hall, R.C.W. and Resnick, P.J.: "Psychotherapy Malpractice: New Pitfalls," Journal of Psychiatric Practice, 14:119-121, 2008.
53. Hammonds MD, Shim SS, Pingfu F, Calabrese JR. Effects of subchronic lithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rat hippocampus. Basic Clin Pharmacol Toxicol 2007;100:356-359.
54. Haro G, Calabrese J, Larsson C, Shirley E, Martin E, Leal C, Delgado P: Relationships between personality traits to substance abuse in patients with bipolar disorder. Eur. Psychiatry. 2007 Jul;22(5):305-8. Epub 2007 May 22.
55. Hatters Friedman S, Heneghan A, Rosenthal M:, Characteristics of Women with Denial of Pregnancy and Concealment of Pregnancy. Psychosomatics, 48: 117-122, 2007.
56. Hatters Friedman S, Loue S:. Incidence and Prevalence of Intimate Partner Violence by and against Women with Severe Mental Illness: A Review. Journal of Women’s Health, 16(4): 471-480; 2007.
57. Hatters Friedman S, Resnick P: Child Murder by Mothers: Patterns and Prevention. World Psychiatry, 2007, 6: 137-141.  Translated into Spanish as Susan Hatters Friedman, MD and Phillip J.Resnick, MD. Asesinato de ninos por sus madres: patrones y prevencion.  World Psychiatry (Edicion en Espanol), 2007; 5(3): 137-141.
58. Hatters Friedman S, Resnick P:. Maternal Neonaticide: Phenomenology and Prevention. International Journal of Law and Psychiatry. 2007, In press.
59. Hatters Friedman S, Stankowski J,  Sajatovic M:. Bipolar Disorder in Women. The Female Patient. 32: 15-24, 2007.
60. Hatters Friedman S MD, Sorrentino R, Stankowski J, Resnick P. Psychiatrists’ Knowledge about Maternal Filicidal Thoughts. Comprehensive Psychiatry, 2008;49(1):106-10.
61. Hatters Friedman S, Holden C, Hrouda D, Resnick P. Maternal Filicide and its Intersection with Suicide. Brief Treatment and Crisis Intervention, 2008, doi:10.1093/brief-treatment/mhn011.
62. Hatters Friedman S, Resnick P. Child Murder by Mothers: Patterns and Prevention. World Psychiatry, Susan Hatters Friedman, MD, Joy Stankowski, MD, and Martha Sajatovic, MD. Bipolar Disorder in Women. The Female Patient. 32: 15-24, 2007
63. Hatters Friedman S, Loue S. Intimate Partner Violence Issues among Mentally Ill Women. Psychiatric Times, 25 (4): 52-53, 2008
64. Hirschfeld RMA, Calabrese J, Frye MA, Lavori PW, Sachs G, Thase ME, Wagner K: Defining the clinical course of bipolar disorder: Response, remission, relapse, recurrence, and roughening. Psychopharmacol Bull. 2007;40(3):7-14.
65. Jaskiw GE, Newbould E, Bongiovanni R. Gamma-butyrolactone-induced dopamine accumulation in prefrontal cortex is affected by tyrosine availability. Eur J Pharmacol. 2008 Jul 28;589(1-3):106-9.
66. Jaskiw GE, Newbould E, Bongiovanni R.  Tyrosine availability modulates potassium-induced striatal catecholamine efflux in vivo. Brain Res. 2008 May 13;1209:74-84.
67. Jaskiw GE, Konicki PE, Fuller MA. Clozapine: toxicity vs. postmortem redistribution. Schizophr Res. 2008 Apr;101(1-3):344-5.
68. Kang HJ, Adams DH, Simen A, Simen BB, Rajkowska G, Stockmeier CA, Overholser JC, Meltzer HY, Jurjus GJ, Konick LC, Newton SS, Duman RS. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci. 2007 Nov 28;27(48):13329-40.
69. Keck PE, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R for the Aripiprazole Study Group: Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo. J Clin Psychiatry. 2007 Oct; 68 (10): 1480-91.
70. Kemp D, Hirschfeld RM, Ganocy SJ, Elhaj O, Slembarski R, Bilali S, Pontau J, Findling RL, Calabrese JR. Screening for bipolar disorder in a county jail at the time of criminal arrest. Jounal of Psychiatric Research, 42, 778-786, 2008
71. Kemp DE, Gao K, Ganocy SJ, Rapport DJ, Elhaj O, Bilali S, Conroy C, Findling RL, Calabrese JR: A 6-month , double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry. In Press.
72. Knoll, J.L., Resnick, P.J.: Deposition Do's and Don'ts: How to Answer 8 Tricky Questions, Current Psychiatry, 7:25-40, 2008.
73. Khawaja I, Gajwani P, Feinstein R. Depression and Cardiovascular Disease: The association, mechanism and therapeutic implication. Cardiology Review. In Press.
74. rystal JH, Carter CS, Geschwind D, Manji HK, March JS, Nestler EJ, Zubieta JK, Charney DS, Goldman D, Gur RE, Lieberman JA, Roy-Byrne P, Rubinow DR, Anderson SA, Barondes S, Berman KF, Blair J, Braff DL, Brown ES, Calabrese JR, Carlezon WA Jr, Cook EH Jr, Davidson RJ, Davis M, Desimone R, Drevets WC, Duman RS, Essock SM, Faraone SV, Freedman R, Friston KJ, Gelernter J, Geller B, Gill M, Gould E, Grace AA, Grillon C, Gueorguieva R, Hariri AR, Innis RB, Jones EG, Kleinman JE, Koob GF, Krystal AD, Leibenluft E, Levinson DF, Levitt PR, Lewis DA, Liberzon I, Lipska BK, Marder SR, Markou A, Mason GF, McDougle CJ, McEwen BS, McMahon FJ, Meaney MJ, Meltzer HY, Merikangas KR, Meyer-Lindenberg A, Mirnics K, Monteggia LM, Neumeister A, O'Brien CP, Owen MJ, Pine DS, Rapoport JL, Rauch SL, Robbins TW, Rosenbaum JF, Rosenberg DR, Ross CA, Rush AJ, Sackeim HA, Sanacora G, Schatzberg AF, Shaham Y, Siever LJ, Sunderland T, Tecott LH, Thase ME, Todd RD, Weissman MM, Yehuda R, Yoshikawa T, Young EA, McCandless R: It is time to take a stand for medical research and against terrorism targeting medical scientists. Biol Psychiatry. 2008 Apr 15;63(8):725-7.
75. Kumra S, Oberstar JV, Sikich L, Findling RL,McClellan JM, Vinogradov S, Schulz,SC. Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophrenia Bulletin, 34, 60-71, 2008
76. Leskovec TJ, Rowles BM, Findling RL. Pharmacological treatment options for autism spectrum disorder in children and adolescents. Harvard Review of Psychiatry, 16, 97-112, 2008
77. Loue S, Sajatovic M. Research with Severely Mentally Ill Latinas: Successful Recruitment and Retention Strategies. Journal of Immigrant and Minority Health 2008; 10(1): (In Press).
78. Mao AR, Findling RL. Growing evidence to support early intervention in early onset bipolar disorder. Australian and New Zealand Journal of Psychiatry, 41, 633-636, 2007
79. Madhusoodanan S, Cuni L, Brenner R, Sajatovic M, Palekar N. Chronic Leukocytosis associated with clozapine use – a case series.  The Journal of Clinical Psychiatry 68(3) 484-8, 2007.
80. Mason P, Gao K, Genzen J. Serotonergic raphe magnus cell discharge reflects on-going autonomic and respiratory activities. J. Neurophysiology 2007; 98:1919-1927.
81. McClellan J, Sikich L, Findling RL, Frazier JA, Vitiello B, Hlastala SA, Williams E, Ambler D, Hunt-Harrison T, Maloney AE, Ritz L, Anderson R, Hamer RM, Koch G, Lieberman JA. The Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS): rationale, design, and methods. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 969-978, 2007
82. McElroy SL, Bowden CL, Collins MA, Wozniak PJ, Keck PE, Calabrese JR: Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder. Journal of Affective Disorders. 2008 Apr;107(1-3):127-33. Epub 2007 Sep 20
83. McNamara NK, Findling RL. Guns, adolescents, and mental illness. American Journal of Psychiatry, 165, 190-194, 2008
84. Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, Thase ME, Calabrese JR, Marangell LB, Ostacher MJ, Patel J, Thomas MR, Araga M, Gonzales JM, Wisniewski SR: Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry 2007 Sept;164(9):1340-7.
85. Miklowitz, D J, Otto MW, Frank E., Reilly-Harrington NA, Wisniewski SR, Kogan JN, Nierenberg AA, Calabrese JR, Marangell LB, Gyulai L, Araga M, Gonzalez JM, Shirley ER, Thase ME, Sachs GS. Is psychosocial management effective? In reply to Saddichha and Kumar. Arch Gen Psychiatry. 2007;64:1452-1453.
86. Miller N, Findling R. Is methylphenidate a safe and effective treatment for ADHD-like symptoms in children with pervasive developmental disorders? Expert Opinion on Pharmacotherapy, 8, 1025-1028, 2007
87. Mossman D, Noffsinger SG, Ash P, Frierson RL, Gerbasi J, Hackett M, Lewis CF, Pinals DA, Scott CL, Sieg KG, Wall BW, Zonana HV. Practice Guideline: Forensic Psychiatric Evaluation of Competence to Stand Trial. The Journal of the American Academy of Psychiatry and the Law. 2007; 35: S3-S72.
88. Moussavand S, Findling RL. Recent advances in the pharmacological treatment of pervasive developmental disorders. Current Pediatric Reviews, 3, 81-93, 2007
89. Nocjar C, Hammonds MD, Shim SS. Chronic lithium treatment magnifies learning in rats.Neuroscience. 2007 Dec 19;150(4):774-88.
90. Nocjar C, Panksepp J.  Prior morphine experience induces long-term increases in social interest and in appetitive behavior for natural reward. Behav Brain Res. 2007 Aug 6;181(2):191-9.
91. Nowakowska C, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, Ketter TA: Increased rate of non-right handedness in patients with bipolar disorder. J Clin Psychiatry. In Press.
92. Ostacher MJ, Nierenberg AA, Iosifescu DV, Eidelman P, Lunda HG, Ametrano RM, Kaczynski R, Calabrese J, Miklowitz DJ, Sachs G, Perlick DA, and the STEP-BD Family Experience Collaborative Study Group. Correlates of subjective and objective burden among caregivers of patients with bipolar disorder. Acta Psychiatr Scand 2008 Jul;118(1):49-56.
93. Pagano, ME. Demeter, C.A., Faber, J.E., Calabrese, JR, & Findling, RL  (2008).  Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar-1 disorder.  Bipolar Disorders, 10, 334-341.
94. Pagano, ME. Phillips, K.A., Stout, R.L., Menard, W., & Piliavin, J.A.  (2007).  The impact of helping behaviors on the course of substance use disorders.  Journal of Studies on Alcohol and Drugs, 68, 291-295.
95. Pagano, ME. Rende, R., Rodriguez, B.F., Hargraves, E.L., Moskowitz, A.T., & Keller, M.B.  (2007).  Impact of parental history of substance use disorders on the clinical course of anxiety disorders.  Substance Abuse Treatment, Prevention, and Policy, 2(13). 
96. Resnick, PJ. "My Favorite Tips for Detecting Malingering and Violence Risk," Psychiatric Clinics of North America, 30:227-232, 2007.
97. Resnick, PJ. The Andrea Yates Case: Insanity on Trial, The 2006 Friedman & Gilbert Criminal Justice Forum, 55 Clev. St. L. Rev. 147, 2007.
98. Resnick, PJ. and Knoll, J.: "Being an Effective Psychiatric Expert Witness," Psychiatric Times, Medicolegal Issues, p. 9-12, November 2007.
99. Rodriguez, B.F., Pagano, ME, Bruce, S.E., & Keller, M.B.  (2007).  Psychometric properties of the Mobility Inventory in a longitudinal study of anxiety disorder: Replicating a three factor solution.  Journal of Anxiety Disorders, 21, 75-761.
100. Romero C, Lindsay JE, Dalton WT, Nelson DV, Friedman LC.  Husbands’ perceptions of wives’ adjustment to breast cancer:  the impact on wives’ mood.  Psycho-Oncology  2008:17;237-243.
101. Sachs G, Nierenberg A, Calabrese J: Antidepressants are not an effective adjunct to mood stabilizers for bipolar depression. Evid Based Ment Health 2007 Nov;10(4):109.
102. Sajatovic M, Valenstein M, Blow F, Ganozcy D, Ignacio R.  Treatment adherence with lithium and anticonvulsant medications in bipolar disorder.  Psychiatric Services. (In Press)
103. Sajatovic M, Jenkins JH.  Is antipsychotic medication stigmatizing for people with mental illness?  International Review of Psychiatry 19(2) 107-12, 2007.
104. Sajatovic M, Fenn H, Chen P, Dines P, Schlachet R.  Treatment considerations in elderly bipolar patients.  Clinical Approaches in Bipolar Disorder.  (In Press) 
105. Sajatovic, M, Elhaj O, Youngstrom EA, Bilali SR, Rapport DJ, Ganocy SJ, Calabrese JR: Treatment adherence in individuals with rapid cycling bipolar disorder – results from a clinical trial setting. J Clin Psychopharmacology 2007 Aug;27(4):412-14.
106. Sajatovic M, Chen PJ, Dines P, Shirley ER: Psychoeducational approaches to medication adherence in patients with bipolar disorder. Disease Management and Health Outcomes 2007;15(3), 181-192.
107. Sajatovic M, Jenkins JH, West JA, Meyer WJ, Calabrese JR: Personal and societal construction of illness among persons with rapid cycling bipolar disorder: A life trajectory perspective. Am J Geriatric Psychiatry. 2007 Dec 10; [Epub ahead of print].
108. Shim SS, Hammonds MD, Ganocy SJ, Calabrese JR Effects of sub-chronic lithium treatment on synaptic plasticity in the dentate gyrus of rat hippocampal slices. Prog Neuropsychopharmacol Biol Psychiatry 31:343-347, 2007
109. Shim SS, Hammonds MD, Vrabel MM.  D-cycloserine augmentation for behavioral therapy.Am J Psychiatry. 2008 Aug;165(8):1050.
110. Shim SS, Hammonds MD, Kee BS.  Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur Arch Psychiatry Clin Neurosci. 2008 Feb;258(1):16-27.
111. Short EJ, Fairchild L, Findling RL, Manos MJ. Developmental and subtype differences in behavioral assets and problems in children diagnosed with ADHD. Journal of Attention Disorders, 11, 28-36, 2007
112. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM. Collaborators: Marangell LB, Calabrese JR, Nierenberg AA, Hauser P, Ketter TA, Thomas M, Patel J, Fossey MD, Gyulai L, Thase ME, Bowden CL, Molay F, Rosen-Sheidley B, Silfies L, Gejman PV, Sanders AR, Amin F, Buccola N, Byerley W, Cloninger CR, Crowe R, Black D, Freedman R, Levinson D, Mowry B, Silverman J, Nurnberger J, Miller MJ, Bowman ES, Rau NL, Moe PR, Samavedy N, El-Mallakh R, Manji H, Glitz DA, Meyer ET, Smiley C, Foroud T, Flury L, Dick DM, Edenberg H, Rice J, Reich T, Goate A, Bierut L, McInnis M, DePaulo JR Jr, MacKinnon DF, Mondimore FM, Potash JB, Zandi PP, Avramopoulos D, Payne J, Berrettini W, Byerley W, Vawter M, Coryell W, Crowe R, Gershon E, Badner J, McMahon F, Liu C, Sanders A, Caserta M, Dinwiddie S, Nguyen T, Harakal D, Kelsoe J, McKinney R, Scheftner W, Kravitz HM, Marta D, Vaughn-Brown A, Bederow L, McMahon FJ, Kassem L, Detera-Wadleigh S, Austin L, Murphy DL: Whole genome association study of bipolar disorder. Mol Psychiatry. 2008 Jun;13(6):558-69. Epub 2008 Mar 4.
113. Skodol, A.E., Bender, D.S., Pagano, M.E., Shea, M.T., Yen, S., Sanislow, C.A., Grilo, C.M., Daversa, M.T., Stout, R.L., Zanarini, M.C., McGlashan, T.H., & Gunderson, J.G.  (2007). Positive childhood experiences: resilience and recovery from personality disorders in early adulthood.  Journal of Clinical Psychiatry, 68(7), 1102-1108.
114. Smarty S, Findling RL. Psychopharmacology of pediatric bipolar disorder: a review. Psychopharmacology, 191, 39-54, 2007
115. Smith, D. and Resnick, P.J.: "Amnesia and Competence to Stand Trial, The Journal of the American Academy of Psychiatry and the Law, 35:541-542, 2007.
116. Stankowski J, Hatters Friedman S, and Sajatovic M.  An updated review of the guidelines for drug treatments for bipolar disorder.  Advances in Schizophrenia and Clinical Psychiatry  3(1):13-18, 2007
117. Stagno SJ, Busby K, Shapiro A, Kotz MM.  Patients at risk:  addressing addiction in patients undergoing hematopoietic stem cell transplantation.  Bone Marrow Transplantation.  In press.
118. Stankowski J, Hatters Friedman S, Sajatovic M.  An Updated Review of the Guidelines for Drug Treatments for Bipolar Disorder.  Advances in Schizophrenia and Clinical Psychiatry, 3(1):13-18, 2007.
119. Syamlal G, Ganocy SJ, et al: Medical determination of fitness for respirator use.  Journal of Occupational and Environmental Medicine. 2007;49(6):691-699.
120. Szewczyk B, Albert PR, Burns AM, Czesak M, Overholser JC, Jurjus GJ, Meltzer HY, Konick LC, Dieter L, Herbst N, May W, Rajkowska G, Stockmeier CA, Austin MC. Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol. 2008 Jun 19;1-14. [Epub ahead of print]
121. The TADS Team. The Treatment for Adolescents with Depression Study (TADS). Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64, 1132-1144, 2007
122. Tham, Y.L., Sexton, K., Weiss, H., Friedman, L.C., & Kramer, R.  The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide (AC) followed by a taxane.  American Journal of Clinical Oncology, 30, 126-132, 2007.
123. Tohen M, Kryzhanovskaya L, Carlson G, DelBello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Huang X, Dittman RW, Biederman J. Olanzapine versus placebo for the treatment of adolescents with bipolar mania. American Journal of Psychiatry, 164, 1547-1556, 2007
124. Tohen M, Calabrese J, Vieta E, Bowden C, Gonzalez-Pinto A, Lin D, Xu W, Coriza S: Effect of comorbid anxiety on treatment response in bipolar depression. J Affective Disorders 2007 Dec;104(1-3):137-46. Epub 2007 May 17.
125. Townsend LD, Demeter CA, Wilson M, Findling RL. Update on pediatric bipolar disorder. Current Psychiatry Reports, 9, 529-534, 2007
126. Townsend L, Demeter CA, Youngstrom EA, Drotar D, Findling RL. Family conflict moderates response to pharmacological intervention in pediatric bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 17, 843-852, 2007 
127. Walsh T, McClellan J, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CV, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King M-C, Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 320, 539-43, 2008
128. Weisler RH, Calabrese JR, Thase ME, Arvekvist R, Stening G, Paulsson B, Suppes T: Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: Combined results from two double-blind, randomized placebo-controlled studies. J Clin Psychiatry. 2008 69:769-82. Apr 29:e1-e14. [Epub ahead of print].
129. Weisler RH, Calabrese JR, Bowden CL, Ascher JA, DeVeaugh-Geiss J, Evoniuk G: Discovery and development of lamotrigine for bipolar disorder: A story of serendipity, clinical observations, risking taking, and persistence. J Affect Disord. 2008 May;108(1-2):1-9. Epub 2007 Nov 14.
130. West S, Hatters Friedman S: To Be or Not to Be: Expert Witness and Treating Psychiatrist. Psychiatric Times, 24 (5): 50-51, 2007.
131. Youngstrom EA, Birmaher B, Findling RL. Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disorders, 10: 194-214, 2008
132. Youngstrom EA, Frazier TW, Demeter C, Calabrese JR, Findling RL. Developing a ten item mania screen form the Parent General Behavior Inventory for children and adolescents. Journal of Clinical Psychiatry, 69, 831-839, 2008
• Books/chapters:

1. Fuller M, Sajatovic M: Drug information Handbook for Psychiatry.  6th Edition. Lexi-Comp., Inc., Cleveland, OH, 2007.
2. Hatters Friedman S, Stankowski J, Loue S:. Intimate Partner Violence and the Clinician. In Simon R, Tardiff K (Eds): The American Psychiatric Press Textbook of Violence Assessment and Mangement. In press.
3. Hatters Friedman S, Sorrentino R, Stankowski J, Resnick P: Psychiatrist Awareness of Filicidal Ideation Among Mothers with Mental Illness.Comprehensive Psychiatry, in press.
4. Knoll, J.L. and Resnick, P.J.: "Insanity Defense Evaluations: Toward a Model for Evidence-Based Practice," Brief Treatment and Crisis Intervention, Oxford University Press, 2007.
5. Pozuelo LP, Locala JA, Whinney CM: Perioperative Management of Psychiatric Disorders in Comprehensive Textbook of Hospital Medicine.  Edited by Cohn SL, In press.
6. Loue S, Sajatovic M, Mendez N, Vargas I: Case Study Seven: Balancing Risks and Benefits in Research With Severely Mentally Ill Participants.  In S. Loue & E. Pike, Case Studies in Ethics and HIV Research.  Springer Publishing, New York.  In press.
7. Loue S, Sajatovic M:  Encyclopedia of Aging and Public Health.  Springer Publishing, New York, NY. 2008
8. Diversity issues in the diagnosis, treatment and research of mood disorders.  Eds:  Loue S, Sajatovic M.  Oxford Press. In press.
9. Madhusoodanan S, Moise D, Sajatovic M: Schizoaffective Disorder in the Elderly. In: Schizophrenia Psychology. Nova Science, New York, NY.  In Press.
10. Sajatovic M, Madhusoodanan S, Fuller MA:  Clozapine in Schizophrenia.  In:  The Clinical Handbook of Schizophrenia.  Eds:  Mueser, K, Jeste, DV.  Publisher:  Guilford Press, New York, NY.  In press.
11. Pozuelo LP, Locala JA, Whinney CM: Preoperative Psychiatric Evaluation and Perioperative Management of Patients with Psychiatric Disorders in Comprehensive Hospital Medicine:An Evidence Based Approach.  Edited by Mark V. Williams. Elsevier, 2007.
12. Sajatovic M, Blow F: Bipolar Disorders in Later Life.  Johns Hopkins Press, Baltimore, MD.  2007.
13. Whinney CM, Pozuelo LP and Locala JA: Evaluation and Management of Medical Patients with Psychiatric Disorders in Comprehensive Hospital Medicine: An Evidence Based Approach.  Edited by Mark V. Williams. Elsevier, 2007.
14. West S, Hatters Friedman S. Filicide: A Research Update. In RC Browne (Ed): Forensic Psychiatry Research Trends. Nova Publishers, 2008.